Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A Professional…
AI in Healthcare and Digital Health Today—January 8, 2026
This roundup covers major developments across artificial intelligence,…
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE + nimacimab in obesity
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE +…
Endocrinology Video Recap—December 16, 2025
This biweekly endocrinology video recap covers major regulatory decisions,…
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…
Obesity Today—December 9, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Public Health Today—5 December, 2025
This Public Health weekly update highlights new evidence shaping behavioural,…
Obesity Today—December 2, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Obesity Today—November 25, 2025
This week’s obesity update brings you the latest clinical advancements,…
Obesity Today—November 18, 2025
Weekly Obesity update featuring major pipeline moves, regulatory and access…
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal…